Discovery of ARF1-targeting inhibitor demethylzeylasteral as a potential agent against breast cancer
Virtual screening
0301 basic medicine
03 medical and health sciences
Breast cancer
Demethylzeylasteral
ADP-ribosylation factor 1
Therapeutics. Pharmacology
RM1-950
Letter to the Editor
DOI:
10.1016/j.apsb.2022.02.011
Publication Date:
2022-02-16T16:54:04Z
AUTHORS (14)
ABSTRACT
Image 1.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (5)
CITATIONS (12)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....